BRD7 and osteosarcoma: Moreover, the BRD7 mutant that was resistant to APC/C degradation was more efficient at suppressing proliferation, colony formation and tumor growth in osteosarcoma (Fig. 4), and a lower level of BRD7 predicts poor prognosis in patients with osteosarcoma (Fig. 6C).